Gemcitabine-induced myositis in a diabetes mellitus patient on hemodialysis

Korean J Intern Med. 2017 Sep;32(5):930-932. doi: 10.3904/kjim.2015.176. Epub 2016 Feb 26.

Authors

June Young Chun¹, Jae Myung Lee¹, Dong Won Ahn¹, Jee Won Chai², Young A Kim³, Kichul Shin¹

Affiliations

¹ Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
² Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
³ Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.

No abstract available

Keywords: Gemcitabine; Myositis; Vasculitis.

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma / complications
Adenocarcinoma / drug therapy*
Adenocarcinoma / secondary
Antimetabolites, Antineoplastic / adverse effects*
Biopsy
Deoxycytidine / adverse effects
Deoxycytidine / analogs & derivatives*
Diabetes Mellitus, Type 2 / complications*
Diabetes Mellitus, Type 2 / diagnosis
Diabetic Nephropathies / diagnosis
Diabetic Nephropathies / etiology
Diabetic Nephropathies / therapy*
Gemcitabine
Humans
Kidney Failure, Chronic / diagnosis
Kidney Failure, Chronic / etiology
Kidney Failure, Chronic / therapy*
Magnetic Resonance Imaging
Male
Middle Aged
Muscle, Skeletal / diagnostic imaging
Muscle, Skeletal / drug effects*
Muscle, Skeletal / pathology
Myositis / chemically induced*
Myositis / diagnosis
Pancreatic Neoplasms / complications
Pancreatic Neoplasms / drug therapy*
Pancreatic Neoplasms / pathology
Renal Dialysis* / adverse effects

Substances

Antimetabolites, Antineoplastic
Deoxycytidine
Gemcitabine